Better FDA-NIH Cooperation Urged To Ease Barriers To Introducing Products
This article was originally published in The Tan Sheet
Executive Summary
FDA and National Institutes of Health staff should compare notes earlier to ensure research conducted under the NIH umbrella also meets the needs of FDA regulators, according to comments at a public meeting sponsored by the agencies
You may also be interested in...
FDA Tackles Regulatory Science Challenge With Help From NIH
The National Institutes of Health will look at investing more in regulatory science if the academic and nonprofit research community shows strong interest in the $6.75 million research program NIH and FDA are funding
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands